Noninvasive Positive Pressure Ventilation During Neonatal Nasal Intubation (IntubAID)

November 14, 2025 updated by: University of Zurich

The IntubAID Study - Noninvasive Positive Pressure Ventilation During Neonatal Nasal Intubation

The goal of this study is to perform a quality control assessment of our local intubation protocol in any newborn infant requiring endotracheal intubation in the delivery room or neonatal intensive care unit at the Department of Neonatology of the University Hospital Zurich. The primary aims are:

  • Successful nasal intubation at the first attempt without physiological instability.
  • Comparison of infants with successful intubation at the first attempt without physiological instability to the infants in the SHINE-Trial in Australia.

Participants will be intubated according to our standard intubation procedure using non-invasive ventilation (NIV) delivered through a nasopharyngeal tube.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zurich, Switzerland
        • University Hospital Zurich

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Any neonate at the Department of Neonatology of the University Hospital Zurich undergoing endotracheal intubation in the delivery room or neonatal intensive care unit.

Exclusion Criteria:

  • Requirement for immediate endotracheal intubation as determined by the treating clinician, without time for potential application of NIPPV, e.g. active cardiopulmonary resuscitation.
  • Contraindication to NIPPV use (e.g. congenital diaphragmatic hernia, abdominal wall defects).
  • Oral intubation planned.
  • Denial of parental consent and/or inability of the parents to understand the study procedures due to cognitive or linguistic reasons.
  • Withdrawal at the discretion of the intubating clinician if he / she feels the study is interfering with a safe and optimal treatment of the patient.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Intubation
Intubation will take place according to our local standard protocol for nasal intubation using non-invasive positive pressure ventilation (NIPPV) delivered through a nasopharyngeal tube. The intubation will be video-recorded to provide a clear view of the procedure and the pulse oximeter displaying the peripheral oxygen saturation (SpO2 [%]) and heart rate (HR [bpm]).
Intubation will take place according to our local standard protocol for nasal intubation using NIPPV delivered through a nasopharyngeal tube. The intubation will be video-recorded to provide a clear view of the procedure and the pulse oximeter displaying the SpO2 and HR.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Successful nasal intubation at the first intubation attempt without physiological instability
Time Frame: first intubation attempt
Number of successful intubations at the first intubation attempt. Physiological instability is defined as the absolute decrease in SpO2 of >20% from baseline and/or bradycardia with a heart rate of <100 bpm for any duration during the first intubation attempt. Baseline is defined as the time immediately before removal of face mask or prong for placement of the nasopharyngeal tube. The intubation starts and ends with the insertion and removal of the laryngoscope blade beyond the infant's lip.
first intubation attempt

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of desaturation
Time Frame: baseline to begin of first intubation attempt
Number of desaturations (SpO2 <80 %) between baseline and the begin of the first intubation attempt
baseline to begin of first intubation attempt
Incidence of bradycardia
Time Frame: baseline to begin of first intubation attempt
Number of bradycardia (HR <100 bpm) between baseline and the begin of the first intubation attempt
baseline to begin of first intubation attempt
Peripheral oxygen saturation
Time Frame: baseline to begin of first intubation attempt
Mean oxygen saturation over time between baseline and the begin of the first intubation attempt, SpO2 [%]
baseline to begin of first intubation attempt
Heart rate
Time Frame: baseline to begin of first intubation attempt
Mean heart rate over time between baseline and the begin of the first intubation attempt, HR [bpm]
baseline to begin of first intubation attempt
Incidence of desaturation
Time Frame: first intubation attempt
Number of desaturations (SpO2 <80 %) during first intubation attempt
first intubation attempt
Incidence of bradycardia
Time Frame: first intubation attempt
Number of bradycardia (Hf <100 bpm) during first intubation attempt
first intubation attempt
Peripheral oxygen saturation
Time Frame: first intubation attempt
Mean oxygen saturation over time during first intubation attempt, SpO2 [%]
first intubation attempt
Heart rate
Time Frame: first intubation attempt
Mean heart rate over time during first intubation attempt, HR [bpm]
first intubation attempt
Time to desaturation during first intubation attempt
Time Frame: first intubation attempt
Time [sec] between time zero and desaturation (SpO2 <80%) during the first intubation attempt. Time zero is defined as the time the laryngoscope is inserted past the infant's lips for the first intubation attempt.
first intubation attempt
Duration of desaturation during first intubation attempt
Time Frame: first intubation attempt
Time of SpO2 spent below 80% during the first intubation attempt
first intubation attempt
Time to bradycardia during first intubation attempt
Time Frame: first intubation attempt
Time [sec] between time zero and bradycardia (HR <100 bpm) during the first intubation attempt.
first intubation attempt
Duration of bradycardia during first intubation attempt
Time Frame: first intubation attempt
Time of HR spent below 100 bpm during the first intubation attempt
first intubation attempt
Duration of intubation attempt(s)
Time Frame: overall intubation procedure
Time from baseline to successful intubation including all intubation attempts, [sec]
overall intubation procedure
Number of intubation attempts
Time Frame: overall intubation procedure
Total number of intubation attempts to successful intubation, [n]
overall intubation procedure
Number of disconnections from ventilator circuit
Time Frame: overall intubation procedure
Total number of disconnections from ventilator circuit between baseline and end of intubation attempt(s), [n]
overall intubation procedure
Incidence of cardiac compressions
Time Frame: Within one hour of first intubation attempt
Incidence of cardiac compressions within one hour after first intubation attempt, [n]
Within one hour of first intubation attempt
Incidence of epinephrine administration
Time Frame: Within one hour of first intubation attempt
Incidence of epinephrine administration within one hour after first intubation attempt, [n]
Within one hour of first intubation attempt
Incidence of pneumothorax requiring drainage
Time Frame: Within 24 hours of first intubation attempt
Incidence of pneumothorax requiring drainage within 24 hours after first intubation attempt, [n]
Within 24 hours of first intubation attempt
Incidence of death
Time Frame: Within 24 hours of first intubation attempt
Incidence of death within 24 hours after first intubation attempt, [n]
Within 24 hours of first intubation attempt

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Dirk Bassler, MD, Newborn Research, Depatrment of Neonatology, University Hospital and University of Zurich

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 31, 2024

Primary Completion (Actual)

October 5, 2025

Study Completion (Actual)

October 5, 2025

Study Registration Dates

First Submitted

November 14, 2023

First Submitted That Met QC Criteria

November 14, 2023

First Posted (Actual)

November 18, 2023

Study Record Updates

Last Update Posted (Actual)

November 18, 2025

Last Update Submitted That Met QC Criteria

November 14, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infant, Newborn, Diseases

Clinical Trials on Intubation

Subscribe